AXA Share Price CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Stocks
CS
FR0000120628
Life & Health Insurance
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.26 EUR | +0.06% |
|
+3.78% | -21.07% |
| 07-13 | AXA : Jefferies reaffirms its Buy rating | ZD |
| 07-09 | Monte dei Paschi and the Generali option, for now on ice | AN |
| Market Cap | 91.1B 104B 84.37B 77.63B 147B 9,941B 150B 1,006B 394B 4,882B 390B 381B 16,859B | P/E 2026 * |
10.7x | P/E 2027 * | 9.85x |
|---|---|---|---|---|---|
| Enterprise Value | 107B 122B 99.01B 91.1B 172B 11,665B 176B 1,180B 463B 5,728B 458B 448B 19,783B | EV / Sales 2026 * |
0.94x | EV / Sales 2027 * | 0.89x |
| Free-Float |
77.71% | Yield 2026 * |
5.63% | Yield 2027 * | 6.06% |
Last Transcript: AXA
| 1 week | +0.10% | ||
| Current month | +0.68% | ||
| 1 month | +8.18% | ||
| 3 months | +7.42% | ||
| 6 months | +13.27% | ||
| Current year | +8.11% |
| 1 week | 43.29 | 44.54 | |
| 1 month | 41.14 | 44.54 | |
| 3 years | 26.28 | 44.54 | |
| 5 years | 20.34 | 44.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Buberl
CEO | Chief Executive Officer | 53 | 31/08/2016 |
| Director of Finance/CFO | - | 30/06/2021 | |
Guillaume Borie
CTO | Chief Tech/Sci/R&D Officer | 40 | 30/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Buberl
BRD | Director/Board Member | 53 | 31/08/2016 |
| Director/Board Member | 68 | 26/04/2016 | |
Helen Browne
BRD | Director/Board Member | 63 | 29/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.06% | +3.78% | +6.36% | +65.94% | 104B | ||
| +0.90% | +0.62% | +7.03% | -9.25% | 95.88B | ||
| 0.00% | -1.61% | +35.68% | +123.78% | 71.93B | ||
| -0.05% | -0.54% | +40.23% | +134.99% | 69.07B | ||
| +1.14% | +2.35% | +21.39% | +76.27% | 62.05B | ||
| +1.51% | +2.84% | +19.73% | +57.22% | 58.97B | ||
| -1.27% | -1.12% | +73.26% | +134.55% | 58.39B | ||
| -1.93% | -1.12% | +30.59% | +65.10% | 44.35B | ||
| +0.42% | +3.53% | +54.72% | +121.79% | 44.01B | ||
| +0.44% | -1.26% | +66.68% | +170.35% | 41.49B | ||
| Average | +0.13% | +0.80% | +35.57% | +94.07% | 60.68B | |
| Weighted average by Cap. | +0.22% | +0.55% | +30.73% | +85.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 114B 130B 106B 97.31B 184B 12,461B 188B 1,261B 494B 6,119B 489B 478B 21,133B | 120B 137B 111B 102B 193B 13,096B 197B 1,325B 520B 6,431B 514B 503B 22,209B |
| Net income | 8.48B 9.67B 7.85B 7.23B 13.67B 925B 13.94B 93.62B 36.72B 454B 36.31B 35.51B 1,569B | 8.96B 10.22B 8.3B 7.64B 14.44B 978B 14.72B 98.92B 38.8B 480B 38.36B 37.52B 1,658B |
| Net Debt | 15.8B 18.01B 14.63B 13.46B 25.47B 1,724B 25.96B 174B 68.41B 847B 67.64B 66.17B 2,924B | 15.8B 18.01B 14.63B 13.46B 25.47B 1,724B 25.96B 174B 68.41B 847B 67.64B 66.17B 2,924B |
Employees
-
Sector
Life & Health Insurance
Calendar
| Date | Price | Change |
|---|---|---|
| 13/07/26 | €44.26 | +0.06% |
| 10/07/26 | €44.23 | +0.03% |
| 09/07/26 | €44.22 | +0.84% |
| 08/07/26 | €43.85 | -1.09% |
| 07/07/26 | €44.33 | +0.27% |
- Stock Market
- Stocks
- CS Stock
- CS Stock
Select your edition
All financial news and data tailored to specific country editions


















